VHL and neoplasm: Decreased gene products associated with VHL mutations lead to increased expression of hypoxia-inducible factor (HIF)-1,2, a hypoxia-inducible factor that enhances angiogenesis into the tumor microenvironment and promotes tumor progression [15].